Engineered endocrine objects tolerate hypoxia in macroencapsulation devices and enable subcutaneous engraftment in diabetic mice

Auteurs : K. Wang, K. Okada, M. Jin, J. Deng, B. Wang, J. A. Flanders, P. L. Tran, M. Lee, M. Ma

bioRxiv preprint
DOI: 10.64898/2026.11.10.765512 - DOI (bioRxiv: Bioengineering)
Publié le 12 Nov. 2026
Résumé scientifique

Islet encapsulation has been pursued for decades as a potential immunosuppression-free transplantation strategy to treat type 1 diabetes (T1D). The encapsulation device protects islets from immune cell-contact mediated killing, but it also prevents vascular penetration and intra-islet vascularization, leading to poor mass transfer and islet central necrosis. In healthy pancreas, islets with sizes > ~40 m are vascularized while non-islet endocrine cell clusters below ~40 m exist without internal capillaries. Here, we developed scalable and reproducible engineered endocrine objects (EEOs) as small as ~47 m by mesh-induced fragmentation of native islets, followed by a recovery culture. Under hypoxic culture condition (1% O2 for 24 hours), EEOs showed enhanced viability of >90%, compared to 49% for the native islet control. With a flat, thin (0.5-mm-thick) alginate-based macroencapsulation device, rat EEOs at a marginal dose of 300 islet equivalents (IEQ) achieved glycemic control for over 5 weeks in the challenging, hypoxic subcutaneous space of immunocompetent diabetic mice. The engrafted mice displayed near-physiological glycemic profiles upon glucose challenge, and the retrieved EEOs showed enhanced viability with significantly reduced central necrosis compared with native islets. Overall, engineering hypoxia-resistance into cellular products mitigates intrinsic constraints of encapsulation devices, offering a promising strategy for convenient, immunosuppression-free subcutaneous islet transplantation.

Les articles autour de lui, par date et par proximité

Plus haut, c’est plus proche de cet article ; à gauche, c’est plus ancien. Les traits relient les articles proches entre eux : les groupes de traits sont des sous-thèmes. Sélectionnez un point pour voir pourquoi il est là. Retour au résumé de cet article

Comment lire cette carte ? Guide illustré

Les articles les plus proches Les travaux antérieurs sur lesquels il s’appuie Les articles qui le citent

Les articles autour de celui-ci

Classés selon la proximité de leur titre et de leur résumé avec ceux de cet article. Sélectionnez-en pour les lire ensemble.

Les articles les plus proches

  1. Très proche Autre approche du problème
    Bridging scale-up to transplantation: pluripotent stem cell-derived pancreatic islet encapsulation in emulsion-generated high concentration alginate beads
    Arianna Castro Rojas, J. Brassard, Marie Billaud et al. · 2026 · bioRxiv · preprint, non relu par les pairs · Pas encore résumé

    Cette étude encapsule des îlots dérivés de cellules souches dans des billes d’alginate concentré pour faciliter leur production à grande échelle et leur greffe.

    Résumé scientifique

    Pluripotent stem cell-derived pancreatic islet-like cell clusters (SC-islets) have emerged as potential cellular therapy for type 1 diabetes. While SC-islets can theoretically be produced in bioreactors to meet transplantation needs of many recipients per batch, biomanufacturing and translational challenges remain. SC-islet can be cultured in suspension using stirred tank or vertical wheel bioreactors, but these can impart hydrodynamic damage and lead to cellular agglomeration, particularly upon scale-up. We previously described a robust emulsion-based process to encapsulate murine pancreatic beta cells in high-concentration alginate beads which improved graft survival in allogeneic recipien…

  2. Très proche Article de revue
    Safe host integration in islet tissue engineering for Type 1 Diabetes Mellitus: emerging technologies and a constraint-guided hybrid islet framework
    Wallace Lung · 2026 · Journal of high school science · Pas encore résumé

    Cette revue examine les approches d’ingénierie des îlots et les compromis entre protection immunitaire, apport en oxygène et intégration de l’hôte.

    Résumé scientifique

    Type 1 diabetes mellitus (T1DM) results from autoimmune destruction of pancreatic β cells and requires lifelong insulin replacement. Islet transplantation can restore endogenous insulin secretion, but donor scarcity, immune rejection, early graft loss, inadequate oxygen delivery, and fibrosis limit its application. This review examines conventional and emerging islet tissue-engineering approaches and proposes a conceptual hybrid bio-artificial islet system (HBAIS). A heuristic constraint-exchange framework compares the functions gained from successive technological additions with their associated risks, overlapping benefits, and operational dependencies. The analysis identifies hypoimmune st…

  3. Très proche Autre approche du problème
    Microgels Containing Protease Resistant CXCL12 and FasL Enable Long-term Allo-Islet Function Without Systemic Immunosuppression.
    F. Doğan, Assia El Babsiri, Esin Ozkan et al. · 2026 · Diabetes · Pas encore résumé

    Cette étude protège localement les allogreffes par des microgels portant FasL et CXCL12, plutôt que par des objets endocriniens conçus tolérant l’hypoxie.

    Résumé scientifique

    ARTICLE HIGHLIGHTS Cotransplantation of allogeneic islets with microgels coated with streptavidin fused with Fas ligand and protease-resistant CXCL12 results in robust and sustained diabetes reversal for over 6 months in streptozotocin-induced diabetic mice and induces local immunomodulation, enhances Treg recruitment within the graft, and improves graft vascularization. This study addresses a critical challenge in cell transplantation, namely the need to develop technologies that enable local immunoprotection of the graft while eliminating the need for systemic immunosuppression. This combination microgel technology could offer a more favorable risk-benefit profile by reducing infection ris…

  4. Proche Autre approche du problème
    Combined B2M Knockout and Alginate Encapsulation Reduces Immune Rejection of iPSC-Derived Pancreatic Progenitors
    P. Ermakova, A. Barinova, Alexandra Y. Bogomolova et al. · 2026 · Cells · Pas encore résumé

    Cette étude combine l’encapsulation d’alginate et l’inactivation de B2M pour réduire le rejet de progéniteurs pancréatiques dérivés d’iPSC.

    Résumé scientifique

    Allogeneic cell replacement therapy for diabetes using induced pluripotent stem cell (iPSC)-derived pancreatic progenitors (PPs) is currently limited by immune rejection. Alginate encapsulation and the genetic ablation of HLA-I via β2-microglobulin (B2M) knockout represent distinct strategies to reduce immune recognition and to protect the transplanted cells. We generated encapsulated B2M-knockout pancreatic progenitors (IPS-∆B2M-PPs) and evaluated their immunogenicity in vitro using each of: peripheral blood mononuclear cell (PBMC) co-culture, natural killer cell (NK cell) degranulation, T-cell activation, and rat macrophage adhesion. In vivo studies were also performed to assess capsule bi…

  5. Proche Contexte plus large
    The capsule was never just a capsule: what islet encapsulation is for, now that immunoisolation is no longer its job
    A. Citro, Lorenzo Piemonti · 2026 · Frontiers in Bioengineering and Biotechnology · Pas encore résumé

    Cet article examine les compromis de l’encapsulation des îlots, notamment entre exclusion immunitaire, transport moléculaire et intégration à l’hôte.

    Résumé scientifique

    For more than four decades, islet encapsulation has been defined by a single objective: to immunoprotect transplanted cells while preserving glucose sensing and insulin delivery, thereby eliminating systemic immunosuppression. No passive device has yet achieved that objective with reproducible, durable and clinically meaningful efficacy. The central limitation is not simply the absence of an optimal polymer, but an over-constrained architecture in which immune exclusion, molecular transport, therapeutic cell dose, host integration, mechanical durability and retrieval must be solved simultaneously. The clinical contrast between sealed and vascularly accessible devices makes this coupling visi…

  6. Proche Autre approche du problème
    Graft Localized Immunomodulation with Rapamycin-Eluting PLGA Microparticles Promotes Murine Islet Allograft Survival and Induces Operational Tolerance.
    Jordan Wong, Purushothaman Kuppan, Nerea Cuesta-Gomez et al. · 2026 · American Journal of Transplantation · Pas encore résumé

    Cette étude prolonge la survie d’allogreffes d’îlots par une libération locale de rapamycine, au lieu de réduire leur sensibilité à l’hypoxie.

    Résumé scientifique

    Islet transplantation effectively restores physiologic glycemic regulation in a subset of individuals living with type 1 diabetes; however, lifelong systemic immunosuppression remains a major barrier to broader patient inclusion. Herein, we explored the use of a localized drug delivery system to preserve islet allograft function, circumventing systemic immunosuppression. Rapamycin (Rapa) was effectively encapsulated within poly(lactic-co-glycolic acid) microparticles (MP), which facilitated sustained and localized drug release to the islet grafts, modulating the immune environment and significantly prolonging allograft survival (p<0.05). Long-term outcomes were further enhanced when Rapa-MP …

  7. Proche Autre approche du problème
    Organotypic vascularization improves maturation of human stem cell-derived islets and restores normoglycemia in diabetic mice.
    Jing-Qiang Wang, A. Pélissier, Jeffrey S. H. Lin et al. · 2026 · Cell Stem Cell · cité 1 fois · Pas encore résumé

    Cette étude améliore la vascularisation et la résistance à l’hypoxie d’îlots dérivés de cellules souches en les associant à des organoïdes vasculaires.

    Résumé scientifique

    Human pluripotent stem cells-derived pancreatic islet organoids (PIOs) hold promise for treating type 1 diabetes, but poor post-transplant survival due to inadequate vascularization remains a major challenge. Here, we generated vascularized PIOs (VPIOs) by co-culturing PIOs with blood vessel organoids (BVOs), resulting in integrated structures with BVOs-derived capillary networks that penetrate into the islet structures. These blood vessels structurally exhibit fenestrations characteristic of islet-specific endothelium and carry a molecular signature of organotypic vasculature. β cells within the VPIOs display partially enhanced maturation and greater resistance to hypoxia and endoplasmic re…

  8. Proche Même méthode, autre problème
    High‐Density Dynamic Culture of Neonatal Porcine Islets Improves Islet Recovery and Function Post‐Transplantation
    Summer A. Helmi, Chelsea Castro, Soren Stachniak et al. · 2026 · Xenotransplantation · Pas encore résumé

    Cette étude optimise une culture dynamique à haute densité pour récupérer et produire des îlots porcins néonataux destinés à la transplantation.

    Résumé scientifique

    ABSTRACT Introduction Type 1 diabetes (T1D) results from autoimmune destruction of pancreatic β‐cells, necessitating lifelong exogenous insulin therapy. Scalable β‐cell replacement strategies are needed to reproducibly increase ß cell production. Neonatal porcine islets (NPIs) are a promising xenogeneic source of ß cells; however, limited manufacturing scalability hinders clinical translation. This study optimizes a dynamic culture system to assess its potential for scalable NPIs production for clinical translation. Methods NPIs were cultured under three conditions: static suspension and dynamic suspension in a PBS Mini Vertical‐Wheel bioreactor at 4.5K (Bio 4.5) and 6.0K (Bio 6.0) NPIs/ml. …

Comment ces articles sont-ils trouvés ?

Nous comparons le titre et le résumé de cet article avec ceux de tous les articles résumés sur ce site, et avec les articles que Semantic Scholar recommande, ceux qu’il cite et ceux qui le citent (pour un article très cité, ses citations les plus récentes et, depuis OpenAlex, les plus citées). Parmi les travaux antérieurs et les suites, les articles qui s’utilisent en profondeur, une méthode qu’il utilise et les suites très citées remontent un peu. Les niveaux (très proche, proche, apparenté) viennent de la similarité des textes, pas d’un jugement de qualité ; * signale un article sans résumé, comparé par son titre. La phrase sous un article est écrite par une IA à partir des deux résumés : vérifiez-la dans les articles. Un article jugé hors sujet par trois lecteurs quitte la liste.

Mis à jour le 16 novembre 2026.

Le guide illustré des articles autour d’un article